{"created":"2021-03-01T06:24:47.194926+00:00","id":19890,"links":{},"metadata":{"_buckets":{"deposit":"e320591c-5c82-4116-9abe-65fe4c0e39ad"},"_deposit":{"id":"19890","owners":[],"pid":{"revision_id":0,"type":"depid","value":"19890"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00019890","sets":["453:456","471:537:538:1158"]},"item_7_alternative_title_1":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"Dose Intensive Chemotherapy with Autologous Bone Marrow Transplantation in Breast Cancer (Application of Autologous BMT to Cancer Treatment)"}]},"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1993-09","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"9","bibliographicPageEnd":"820","bibliographicPageStart":"815","bibliographicVolumeNumber":"107","bibliographic_titles":[{"bibliographic_title":"新潟医学会雑誌"},{"bibliographic_title":"新潟医学会雑誌","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Autologous bone marrow transplantation （ABMT） was first introduced in 1979, and by the end of 1991, 61 patients with recurrent/advanced breast cancer were treated with ABMT-supported chemotherapy, and their responses appeared superior to those obtained with conventional chemotherapy. Although there have been some prolonged disease-free survivors and some of them may have been actually cured, these cases have been exceptional. It was thus felt that ABMT-supported chemotherapy should also be applied for patients with mimimum tumor residue with no prior chemotherapy. 59 patients with alleged high risk for recurrence have been enrolled in adjuvant ABMT-supported chemotherapy trial, with the longest follow-up period being 137 months. There were 23 patients who had 10 or more positive lymphnodes, and they showed 38.5% 5 year relapse-free survival（RFS）, which was in contrast to 10.0% in 30 patients treated with conventional postoperative adjuvant therapy. There were 10 patients who had been treated more than 5 years ago, and their 5 year RFS was 50.0% contrasting to 14.0% in 19 control patients. The chemotherapeutic regimen used in adjuvant was rather modest, since death is least acceptable in these situations.","subitem_description_type":"Abstract"}]},"item_7_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"123312","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Tajima, Tomoo"}]}]},"item_7_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"新潟医学会"}]},"item_7_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00182415","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00290440","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"田島, 知郎"}],"nameIdentifiers":[{"nameIdentifier":"123311","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-16"}],"displaytype":"detail","filename":"107(9)_815-820.pdf","filesize":[{"value":"1.3 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"107(9)_815-820.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/19890/files/107(9)_815-820.pdf"},"version_id":"5e532ce6-6493-4aaa-98dc-50f9ff49d033"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"autologous bone marrow transplantation","subitem_subject_scheme":"Other"},{"subitem_subject":"breast cancer chemotherapy","subitem_subject_scheme":"Other"},{"subitem_subject":"adjuvant chemotherapy","subitem_subject_scheme":"Other"},{"subitem_subject":"自家骨髄移植","subitem_subject_scheme":"Other"},{"subitem_subject":"乳癌化学療法","subitem_subject_scheme":"Other"},{"subitem_subject":"乳癌補助化学療法","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"7）乳癌の自家骨髄移植療法(シンポジウム 自家骨髄移植の応用, 第482回新潟医学会)","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"7）乳癌の自家骨髄移植療法(シンポジウム 自家骨髄移植の応用, 第482回新潟医学会)"},{"subitem_title":"7）乳癌の自家骨髄移植療法(シンポジウム 自家骨髄移植の応用, 第482回新潟医学会)","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["456","1158"],"pubdate":{"attribute_name":"公開日","attribute_value":"2016-02-05"},"publish_date":"2016-02-05","publish_status":"0","recid":"19890","relation_version_is_last":true,"title":["7）乳癌の自家骨髄移植療法(シンポジウム 自家骨髄移植の応用, 第482回新潟医学会)"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:50:46.509455+00:00"}